Core Viewpoint - Meirya has received an administrative penalty notice from the Hubei Securities Regulatory Bureau due to violations related to the non-disclosure of related party transactions involving non-operating fund occupation [1][2]. Group 1: Administrative Penalty - Meirya and its actual controller, Chairman Zheng Jiping, received a notice of administrative penalty on January 9, 2026, following a prior notice of investigation on April 18, 2025 [1]. - The main violation involves failing to timely disclose non-operating fund occupation related party transactions, with amounts of 71.5 million yuan from November to December 2022, accounting for 9.42% of the latest audited net assets [2][5]. - In the first half of 2023, the amount was 32.22 million yuan, representing 5.12% of the latest audited net assets [2][5]. Group 2: Financial Performance - For the first three quarters of 2025, Meirya reported total operating revenue of 172 million yuan, a year-on-year decrease of 33.12% [3][6]. - The net profit attributable to shareholders was a loss of 35.68 million yuan, compared to a loss of 48.56 million yuan in the same period last year [3][6]. - The net cash flow from operating activities was -1.18 million yuan, an improvement from -61.61 million yuan in the previous year [3][6]. Group 3: Investor Compensation - Investors who purchased Meirya shares between April 29, 2023, and April 29, 2024, and sold or held them after April 30, 2024, may be eligible for compensation due to the administrative penalty [4][6].

专门从事股票索赔法律事务的上海久诚律师事务所主任许峰律师认为，在2024年3月13日到2024年3 月15日之间买入天宜上佳股票，并且在2024年3月15日后卖出或继续持有股票的投资者，目前还可提起 索赔。（天宜新材维权入口） （本文由上海久诚律师事务所主任许峰律师供稿，不代表新浪财经立场。许峰律师，2008年起律师执 业，执业服务范围涉及虚假陈述、内幕交易、操纵市场等证券欺诈领域索赔代理。十几年来已代理近两 百只股票的投资者胜诉或调解获赔，同期还在代理诉讼时效内近三百只股票的索赔案件，部分也已有胜 诉以及调解获赔先例。投资者不获赔没有任何费用。执业证号：13101200810965495） 登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 2026年1月9日，上海久诚律师事务所股票索赔律师许峰代理的天宜上佳（688033，天宜新材（维权）） 虚假陈述引发的投资者索赔案再向上海金融法院提交一次立案。（ ...

Core Viewpoint - Future Co. (600532) is facing legal actions due to false statements leading to inflated revenue and profits, with a significant portion of its financial reports being misleading [2][4]. Group 1: Legal Proceedings - The Shanghai Financial Court has accepted a case for investor compensation against Future Co., with a loss assessment report expected to lead to formal court proceedings soon [1][3]. - Investors who purchased Future Co. shares between October 29, 2022, and April 25, 2023, and sold or held their shares after April 25, 2023, are eligible to file for compensation, as the statute of limitations is approaching [3][5]. Group 2: Financial Misconduct - In the second half of 2022, Future Co. engaged in fraudulent activities by fabricating coal trading business transactions, which resulted in inflated revenues and profits in their financial reports [2][4]. - The third-quarter report of 2022 showed inflated operating revenue of approximately 955.76 million yuan, accounting for 95.20% of the reported revenue, and an inflated profit of about 11.84 million yuan, representing 29.26% of the total profit [2][4]. - The annual report for 2022 indicated inflated operating revenue of approximately 110.33 million yuan, which was 66.61% of the reported revenue, and an inflated profit of the same amount, constituting 837.84% of the total profit [2][4].

Core Viewpoint - The company Yishite (300376) is facing legal actions due to false statements that inflated its revenue, costs, and profits from 2017 to 2021, leading to investor claims for compensation [2][3][7]. Group 1: Legal Proceedings - Yishite has had multiple cases filed in court regarding investor compensation, with some cases already receiving court assessment reports and moving towards settlement [1][3]. - The law firm Shanghai Jucheng, led by lawyer Xu Feng, is actively accepting claims from investors who purchased Yishite shares between March 15, 2018, and May 12, 2023, and either sold or held their shares after May 12, 2023 [3][7]. Group 2: Regulatory Findings - The China Securities Regulatory Commission (CSRC) issued an administrative penalty decision against Yishite, confirming that the company engaged in false trading activities to inflate its operating income, costs, and total profits [2][4]. - Yishite's fraudulent activities included false trade operations, financing-related procurement, agency businesses, and data center integration services, all lacking commercial substance [3][6][7].

Core Viewpoint - The article discusses the legal actions taken against Puli Pharmaceutical due to false reporting of sales revenue and profits, leading to investor claims and a recent appeal by the company against a favorable ruling for investors [1][3]. Financial Misreporting - Puli Pharmaceutical falsely reported sales revenue and profits by fabricating sales of finished and raw pharmaceutical products from 2021 to 2022. In 2021, the company overstated revenue by 436,606,838.34 yuan, which was 28.94% of the reported revenue, and overstated profit by 308,018,435.49 yuan, accounting for 65.88% of the reported profit [1][5]. - In 2022, the company overstated revenue by 456,639,341.72 yuan, representing 25.28% of the reported revenue, and overstated profit by 387,417,257.52 yuan, which was 88.27% of the reported profit [1][4]. Additional Revenue Misstatements - Puli Pharmaceutical also misreported revenue from non-controlling trade activities, leading to an additional overstatement of revenue by 77,997,346.38 yuan in 2021 (5.17% of reported revenue) and 59,259,735.84 yuan in 2022 (3.28% of reported revenue) [2][4]. Legal Proceedings and Investor Claims - The law firm representing investors, Shanghai Jiucheng Law Firm, is continuing to accept claims from investors who purchased Puli Pharmaceutical stock between April 26, 2022, and April 17, 2024, and subsequently sold or held the stock after April 17, 2024 [3][5]. - The firm has a history of successfully representing investors in similar cases, with nearly 200 cases won or settled favorably [3].

Core Viewpoint - The article discusses ongoing legal actions against Guandong Network and Hainan Huatie for false statements and incomplete disclosures, leading to potential investor claims for compensation. Group 1: Guandong Network - Guandong Network's investor compensation case has been accepted by the court, with multiple filings ongoing for further claims [1][7] - The company was found to have falsely recognized debt restructuring income in 2022, leading to inflated profits by 23.52 million yuan, which is 118.95% of the audited profit total of 19.77 million yuan [2][7] - Following the correction announcement in April 2024, Guandong Network's financial statements shifted from profit to loss [2][7] Group 2: Hainan Huatie - Hainan Huatie's investor compensation case has also been filed, with ongoing acceptance of claims from other investors [3][8] - The company received a notice from the regulatory authority regarding incomplete disclosures related to a significant contract worth 3.69 billion yuan, which was not fully disclosed in their announcements [5][8] - Investors who purchased Hainan Huatie shares between March 5, 2025, and October 1, 2025, may also initiate claims [5][8]

Core Viewpoint - Longyu Co., Ltd. (龙宇股份) is facing legal actions due to false statements in its financial reports, leading to investor claims and penalties from regulatory authorities [2][5]. Group 1: Legal Actions and Investor Claims - The Shanghai Jucheng Law Firm, represented by lawyer Xu Feng, has successfully filed a lawsuit against Longyu Co., Ltd. for false statements, with some investors already winning their cases [1][4]. - Investors who purchased Longyu shares between April 28, 2020, and April 30, 2024, and sold or held their shares after April 30, 2024, are eligible to initiate claims [3][6]. Group 2: Regulatory Findings - Longyu Co., Ltd. has been found to have inflated its revenue and profits in annual reports from 2019 to 2022 through fictitious trade practices, resulting in significant discrepancies in reported figures [2][5]. - Specific figures include: - 2019: Revenue inflated by 224.23 million yuan (16.61% of reported revenue), profit inflated by 573 thousand yuan (60.48% of reported profit) [2][5]. - 2020: Revenue inflated by 398.58 million yuan (44.57%), profit inflated by 1.11 million yuan (10.36%) [2][5]. - 2021: Revenue inflated by 402.42 million yuan (50.46%), profit inflated by 951.95 thousand yuan (7.48%) [2][5]. - 2022: Revenue inflated by 428.82 million yuan (42.95%), profit inflated by 1.09 million yuan (23.92%) [2][5].

Group 1 - The core issue involves investor claims against Qidi Design (300500) due to false statements leading to legal actions initiated by investors [1][5] - On December 31, 2025, Qidi Design received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into information disclosure violations [1][5] - Investors who purchased Qidi Design shares between April 29, 2021, and January 1, 2026, and sold or held the shares after January 1, 2026, are eligible to file claims [5] Group 2 - The investor claim case against Silver Jiang Technology (300020) has been submitted multiple times to the Hangzhou Intermediate People's Court, with ongoing efforts to accept additional claims from investors [2][5] - On April 21, 2025, Silver Jiang Technology received an administrative penalty decision from the CSRC, revealing several violations including failure to disclose non-operating fund occupation and significant omissions in financial reports from 2018 to 2023 [2][3][5] - Investors who bought Silver Jiang Technology shares between April 19, 2019, and April 30, 2024, and sold or held the shares after April 30, 2024, can also initiate claims [4][5]

Group 1 - The law firm Shanghai Jiucheng, represented by lawyer Xu Feng, has filed a lawsuit against Pava Co., Ltd. (688184) for alleged false statements, with the case submitted to the Shanghai Financial Court [1] - The China Securities Regulatory Commission (CSRC) has issued a notice of case filing against Pava Co., Ltd. and its director Zhang Bao for violations of information disclosure laws [1] - Pava Co., Ltd. received a warning from the Zhejiang Securities Regulatory Bureau on March 25, 2025, and a decision from the public security bureau on August 1, 2025, regarding Zhang Bao's alleged embezzlement [1] Group 2 - Investors who purchased Pava Co., Ltd. stock between September 19, 2022, and March 26, 2025, and sold or continued to hold the stock after March 26, 2025, are eligible to initiate claims [2] - Xu Feng has extensive experience in securities fraud cases, having represented nearly 200 stocks in successful claims or settlements over the years [2] - Investors are not required to pay any fees if they do not receive compensation [2]

2025年12月9日晚，惠伦晶体公告公司及相关当事人收到广东证监局下发的《行政处罚事先告知书》， 经查明，惠伦晶体、赵积清涉嫌信息披露违法违规的事实如下： 一、惠伦晶体未按规定披露资金占用事项，2020年年度报告存在重大遗漏2020年，惠伦晶体以采购设备 及材料、预付工程款等名义向东莞市某科技有限公司等7家公司支出款项，并最终划转至控股股东新疆 惠伦股权投资合伙企业（有限合伙）（以下简称新疆惠伦）及公司实际控制人赵积清本人等关联方银行 账户，用于归还新疆惠伦股权质押款及赵积清个人借款。上述关联方非经营性资金往来构成关联方对公 司的资金占用，2020年累计发生额为28，330，000元，期末余额为26，630，000元，资金占用发生额占 惠伦晶体2020年年度报告披露净资产的5.12%。截至2025年3月，关联方已归还上述占用资金及利息。 登录新浪财经APP 搜索【信披】查看更多考评等级 2025年12月31日，上海久诚律师事务所股票索赔律师许峰代理的惠伦晶体（300460）虚假陈述引发的投 资者索赔案再向法院提交一次立案。（许峰律师专栏） 许峰律师代理的惠伦晶体投资者索赔案此前已向法院提交立案，律师团队还在继 ...